The objective of the scheme is to generate income by investing in debt and money market instruments, with Macaulay duration of the portfolio between 6 to 12 months. However, there is no assurance that
Read MoreThe investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the CRISIL-IBX 10:90 Gilt + SDL Index - Dec 2029
Read MoreTo achieve long term capital appreciation by predominantly investing in equity and equity related instruments by investing through a Momentum factor-based approach for stock selection. However, there
Read MoreThe investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of the BSE Select IPO Total Return Index, subject to tracking error. The sche
Read MoreThe investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of the BSE 200 Equal Weight Total Return Index, subject to tracking error. Th
Read MoreThe investment objective of the scheme is to generate returns that are commensurate (before fees and expenses) with the performance of CRISILIBX Financial Services 3-6 Months Debt Index that seeks to
Read MoreThe investment objective of the scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of mid cap companies. Howev
Read MoreThe investment objective of the scheme is to generate returns that are in line with the performance of physical gold in domestic prices, subject to tracking error. However, there is no assurance that
Read MoreThe investment objective of the scheme is to provide returns that, before expenses, corresponding to the total returns of the securities as represented by the underlying index, subject to tracking err
Read MoreThe investment objective of the scheme is to generate returns that are commensurate with the performance of the Nifty Private Bank Index, subject to tracking error. There is no assurance that the inve
Read More